Genedrive PLC genedrive plc to Present at the UK Investor Show
18 April 2018 - 4:01PM
RNS Non-Regulatory
TIDMGDR
Genedrive PLC
18 April 2018
For release RNS Reach: 18 April 2018
genedrive plc ("genedrive" or the "Company")
genedrive plc to Present at the UK Investor Show
genedrive plc (AIM: GDR), the near patient molecular diagnostics
company, today announces that David Budd, CEO and Matthew Fowler,
CFO, will be attending the UK Investor Show, Britain's largest one
day investor event.
The event will take place on Saturday 21(st) April 2018 at the
Queen Elizabeth II Conference Centre in Westminster, London. The
Company will be based at stand 72 from 8.30am until 5.30pm to
discuss genedrive's recent progress and growth strategy with
existing and prospective investors.
For more details on the event please visit:
www.ukinvestorshow.com
- Ends -
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
Matthew Fowler: CFO
Peel Hunt LLP
James Steel +44 (0)207 418 8900
Oliver Jackson
Stanford Capital Partners Limited +44 (0) 0203 815 8880
Patrick Claridge
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
Notes to Editors
About genedrive plc
genedrive plc is a molecular diagnostics company developing and
commercialising a low cost, rapid, versatile, simple to use and
robust point of need molecular diagnostics platform for the
diagnosis of infectious diseases and for use in patient
stratification (genotyping), pathogen detection and other
indications. The Genedrive(R) HCV-ID test has received CE-IVD
Certification and has been launched in Africa and Asia Pacific.
genedrive has distribution agreements with subsidiaries of Sysmex
Corporation for the distribution of the Genedrive(R) platform in
the EMEA and SE Asia (ex India), and with ARKRAY Healthcare pvt Ltd
for the distribution of the Genedrive(R) HCV ID Kit and
Genedrive(R) platform in India.
Further details can be found at: www.genedriveplc.com and
www.genedrive.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAUBAARWAASAUR
(END) Dow Jones Newswires
April 18, 2018 02:01 ET (06:01 GMT)
Epistem (LSE:EHP)
Historical Stock Chart
From Apr 2024 to May 2024
Epistem (LSE:EHP)
Historical Stock Chart
From May 2023 to May 2024